A study for evaluating the effect of the intake of GABA at daytime on sleep: randomized, placebo-controlled, double blind trial, cross-over study
Not Applicable
- Conditions
- Healthy adult
- Registration Number
- JPRN-UMIN000030360
- Lead Sponsor
- Pharma Foods International Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 16
Inclusion Criteria
Not provided
Exclusion Criteria
1) Subjects who routinely use food supplements or medicine containing GABA. 2) Subjects who take care for the improvement of mental fatigue, quality of sleep and stress. 3) Subjects who have been diagnosed for and who are under any medical treatment. 4) Subjects who have history of the medical treatment and who are under the medical treatment for diabetes, liver disease, kidney disease, or heart disease. 5) Subjects who are planning to become pregnant and who are lactating. 6) Subjects who are judged as unsuitable for the study by doctor for other reasons.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Measurement of EEG during sleep (Mesurement time: before and after the intake of the sample)
- Secondary Outcome Measures
Name Time Method -Sleep, Stress, and Mental Fatigue: VAS -Sleep: OSA -Sleep: PSQI-j (Mesurement time: before and after the intake of the sample)